Avant Technologies JV with Austrianova Paves Way for Klotho-Based Therapies in Aging Biotech Sector

Avant Technologies has formed a joint venture with Austrianova to develop cell-based therapies using encapsulated Klotho-producing cells for age-related conditions. The partnership leverages Austrianova's proprietary cell-encapsulation technology and intellectual property. Avant provides capital and operational resources to accelerate Klothonova's development pipeline, positioning the company to capitalize on the growing demand for precision healthcare solutions.